Archives
-
CLCC1 and Herpesvirus Nuclear Egress
2026-08-26
The reference study identifies CLCC1 as a host factor required for the membrane-fusion step of herpesvirus nuclear egress, resolving a major gap between viral budding and capsid release into the cytoplasm. A whole-genome CRISPR screen with HSV-1 connects CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and defects in nuclear pore complex insertion, suggesting an ancient membrane-remodeling function.
-
Exemestane Workflows for Aromatase Research
2026-08-26
Build reproducible aromatase assays and hormone-dependent breast cancer models around Exemestane, a steroidal aromatase inhibitor with irreversible target engagement. This practical guide connects enzyme inhibition, washout experiments, biomarker-defined models, and troubleshooting for stronger estrogen biosynthesis studies.
-
Pseudo-UTP: Designing Better mRNA Experiments
2026-08-25
Pseudo-UTP is a pseudouridine-containing nucleotide for controlled mRNA synthesis and RNA stability enhancement. This article connects nucleotide chemistry with antigen-design decisions, assay controls, and practical workflow planning for mRNA vaccine development and gene therapy RNA modification.
-
Alosetron in Intestinal Polarity Research
2026-08-25
Alosetron provides a temporally controllable 5-HT3 receptor antagonist workflow for separating serotonin-driven gastrointestinal responses from epithelial stem-cell and polarity phenotypes. This guide integrates receptor pharmacology with CDC42–YAP–EGF–mTOR assay design, emphasizing practical dosing, controls, and troubleshooting rather than implying an unproven direct pathway connection.
-
How Sodium Overload Drives NECSO
2026-08-24
Qiao and colleagues identify a mitochondrial mechanism linking TRPM4-mediated sodium influx to necrosis by sodium overload, or NECSO. The study shows that mitochondrial sodium accumulation disrupts NCLX-dependent calcium handling, oxidative phosphorylation, and TCA-cycle activity, producing ATP failure and eventual loss of cellular integrity.
-
Sulfo-NHS-SS-Biotin Kit: Reliable Surface Assays
2026-08-24
Learn how Sulfo-NHS-SS-Biotin Kit (SKU K1006) supports reversible protein labeling, cell-surface studies, purification, and orthogonal interpretation of viability or cytotoxicity experiments. This scenario-based guide covers chemistry, workflow parameters, data controls, and practical vendor-selection criteria.
-
Alosetron in Gut Signaling Research
2026-08-23
Explore how Alosetron, a selective 5-HT3 receptor antagonist, can be used to interrogate gut receptor signaling without conflating it with CDC42-driven epithelial polarity. This article translates intestinal stem-cell findings into practical assay design and interpretation.
-
Ivermectin: Assay Design from Parasites to PDAC
2026-08-22
Ivermectin is a broad-spectrum anti-parasitic research compound whose value depends on rigorous exposure, handling, and endpoint design. This guide uses a recent Gasdermin C study to show how mechanistic validation can improve parasitology assays without overstating oncology applications.
-
Tacrolimus (FK506) Experimental Workflow Guide
2026-08-21
Build more reproducible calcineurin-inhibition assays with Tacrolimus (FK506), from solvent preparation and T-cell stimulation to cytokine readouts and animal-model translation. The workflow separates literature-backed dosing from practical optimization, while using cyclosporine-resistance genetics to sharpen mechanistic interpretation.
-
Stattic Workflows for STAT3 Signaling Research
2026-08-21
Stattic is a practical STAT3 inhibitor for connecting pathway mechanism with apoptosis, radiosensitization, and treatment-resistance assays. This guide translates STAT3 biology into reproducible cell-based workflows while showing how microbiome-driven signaling findings can inform cancer biology experiments.
-
Hypoxia, Immunometabolism, and Tumor Redox Biology
2026-08-20
This 2025 review presents tumor hypoxia as an organizing force that links metabolic reprogramming, nutrient competition, immune-cell dysfunction, and immunosuppressive microenvironment formation. Its main practical implication is that tumor metabolism and immune metabolism should be studied as an interacting system, with spatially and redox-aware measurements used to evaluate therapeutic responses.
-
mRNA Vaccine Protects Dairy Cows From H5N1
2026-08-20
A hemagglutinin-based mRNA–lipid nanoparticle vaccine protected lactating dairy cows from high-dose H5N1 challenge without detectable effects on health or milk production. The study is notable for demonstrating durable protection in a production-relevant host, including protection in some animals despite very low late serum antibody levels.
-
Poria cocos, NRF2, and Ferroptosis in ALD
2026-08-19
The reference study identifies NRF2-regulated ferroptosis as a mechanistic link between oxidative stress and alcoholic liver disease, showing that Poria cocos polysaccharides reduce liver injury in alcohol-exposed rat and cell models. Its use of ferrostatin-1 and ML385 provides pharmacological support for a protective pathway involving NRF2 activation, iron handling, lipid peroxidation, and inflammatory signaling.
-
Light-Inducible RNA Release for Gene Therapy Control
2026-08-19
The reference study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that regulates mammalian translation without requiring a separate transcriptional effector domain. In mouse models, LIRP-based switches controlled therapeutic activity in skin and retina, showing how light-accessible gene regulation could improve temporal control and safety in gene therapy.
-
LDH Cytotoxicity Assay Kit: Practical Workflow
2026-08-18
The LDH Cytotoxicity Assay Kit, SKU K2228, provides a non-radioactive method for measuring cell membrane damage through LDH released into culture medium. It is appropriate for comparative cytotoxicity and cell damage quantification, but it should not be used alone to identify apoptosis or distinguish apoptosis from other forms of membrane injury.